Benoxaprofen improves psoriasis. A double-blind study.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Archives of Dermatology

• Publication date

  1983-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHDERM.1983.01650310010002PMID 6407402
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4

  1983cited by this paper
• Stripping of the stratum corneum in patients with psoriasis: production of prepinpoint papules and psoriatic lesions.

  1982cited by this paper
• Phototoxicity to benoxaprofen.

  1982cited by this paper
• The phototoxic effects of benoxaprofen and their management and prevention.

  1982cited by this paper
• Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products.

  1982cited by this paper
• Benoxaprofen: side-effect profile in 300 patients.

  1982cited by this paper
• A study of benoxaprofen‐induced photosensitivity

  1982cited by this paper
• Stripping of the stratum corneum in patients with psoriasis: production of prepinpoint papules and psoriatic lesions.

  1982cited by this paper
• Treatment of nodular prurigo with benoxaprofen

  1982cited by this paper
• Fatal cholestatic jaundice in elderly patients taking benoxaprofen.

  1982cited by this paper
• Benoxaprofen*

  1982cited by this paper
• The pharmacology of benoxaprofen with particular to effects on lipoxygenase product formation.

  1982cited by this paper
• An update on long-term efficacy and safety with benoxaprofen.

  1982cited by this paper
• Toxic epidermal necrolysis, leucopenia and thrombocytopenic purpura—a further complication of Benoxaprofen therapy

  1982cited by this paper
• Benoxaprofen: effect on cutaneous lesions in psoriasis.

  1982cited by this paper
• Psoriasis and leukotriene B4.

  1982cited by this paper
• An update on long-term efficacy and safety with benoxaprofen.

  1982cited by this paper
• Commentary: Cyclic Adenosine Monophosphate Regulation of Normal and Psoriatic Epidermis

  1982cited by this paper
• Phototoxicity to benoxaprofen.

  1982cited by this paper
• The pharmacokinetics of benoxaprofen in elderly subjects.

  1982cited by this paper
• Side effects of benoxaprofen.

  1982cited by this paper
• Association between Stevens-Johnson syndrome and benoxaprofen.

  1981cited by this paper
• Mediation of local homeostasis and inflammation by leukotrienes and other mast cell-dependent compounds

  1981cited by this paper
• Failure of ejaculation with indoramin.

  1981cited by this paper
• EXACERBATION OF PSORIASIS INDUCED BY INDOMETHACIN

  1981cited by this paper
• Transient neutropenia due to benoxaprofen.

  1980cited by this paper
• The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs).

  1980cited by this paper
• Cyclic GMP metabolism in psoriasis: activation of soluble epidermal guanylate cyclase by arachidonic acid and 12-hydroxy-5,8,10,14-eicosatetraenoic acid.

  1980cited by this paper
• Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes

  1980cited by this paper
• Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187.

  1979cited by this paper
• Cyclic nucleotide levels in psoriatic and normal keratomed epidermis.

  1979cited by this paper
• Inflammatory and immune cell function in psoriasis: II. Monocyte function, lymphokine production.

  1978cited by this paper
• Enhanced chemotactic and phagocytic activities of leukocytes in psoriasis vulgaris.

  1978cited by this paper
• Prostaglandins and thromboxanes.

  1978cited by this paper
• The pharmacology of benoxaprofen (2‐[4‐chlorophenyl]‐α‐methyl‐5‐benzoxazole acetic acid), LRCL 3794, a new compound with anti‐inflammatory activity apparently unrelated to inhibition of prostaglandin synthesis

  1977cited by this paper
• Glucocorticoid in inflammatory proliferative skin disease reduces arachidonic and hydroxyeicosatetraenoic acids.

  1977cited by this paper
• Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis.

  1975cited by this paper
• Photosensitivity and photo-onycholysis due to demethylchlortetracycline.

  1961cited by this paper

• Synthesis and In-Vivo Evaluation of Benzoxazole Derivatives as Promising Anti-Psoriatic Drugs for Clinical Use

  2022cites this paper
• Cutaneous liver X receptor activation prevents the formation of imiquimod-induced psoriatic dermatitis.

  2021cites this paper
• Association Between Daily Dietary Eicosatetraenoic Acid Intake and the Lower Risk of Psoriasis in American Adults

  2021cites this paper
• How lifestyle factors and their associated pathogenetic mechanisms impact psoriasis.

  2020cites this paper
• What's New in Psoriasis.

  2019cites this paper
• A Review of Drugs that Induce or Exacerbate Psoriasis

  2012cites this paper
• Dermatologic drugs withdrawn by the FDA for safety reasons

  2012cites this paper
• Psoriasis: What Has Failed and Why

  2011cites this paper
• Inflammatory Disease Processes and Interactions with Nutrition

  2009cites this paper
• Inflammatory Disease Processes and Interactions with Nutrition

  2009cites this paper
• Cannabinoids, loratadine and allopurinol as novel additions to the antipsoriatic ammunition

  2005cites this paper
• Milia en placa en varias y sucesivas áreas

  2005cites this paper
• Reduction of lipoxygenase products in psoriatic skin homogenates by QA 208-199

  2004cites this paper
• In vitro inhibition of leukotriene B4 formation by exogeneous 5-lipoxygenase inhibitors is associated with enhanced generation of 15-hydroxy-eicosatetraenoic acid (15-HETE) by human neutrophils

  2004cites this paper
• Chemotactic lipoxygenase products in sera from patients with psoriasis

  2004cites this paper
• Meta-analysis of dyspepsia and nonsteroidal antiinflammatory drugs.

  2003cites this paper
• Do NSAIDs cause dyspepsia? a meta-analysis evaluating alternative dyspepsia definitions

  2002cites this paper
• A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs.

  2002cites this paper
• NSAIDs in Dermatologic Therapy: Review and Preview

  2002cites this paper
• NSAIDS in Dermatologic Therapy: Review and Preview

  2002cites this paper
• VML 295 (LY‐293111), a novel LTB4 antagonist, is not effective in the prevention of relapse in psoriasis

  2000cites this paper
• [Immunonutrition with omega-3-fatty acids. Are new anti-inflammatory strategies in sight?].

  2000cites this paper
• Preview of Potential Therapeutic Applications of Leukotriene B4 Inhibitors in Dermatology

  2000cites this paper
• Psoriasis, lichen planus, and disorders of keratinization: unapproved treatments or indications.

  2000cites this paper
• Milia en plaque

  2000cites this paper
• Psoriasis and the arachidonic acid cascade.

  1999cites this paper
• Selected drug complications and treatment conflicts in the presence of coexistent diseases.

  1999cites this paper
• 6-Amino-2,4-lutidine carboxamides: α-aminoamide derivatives as systemic and topical inflammation inhibitors

  1998cites this paper
• [Childhood plaque milia of the inner canthus].

  1998cites this paper
• Drugs in exacerbation and provocation of psoriasis.

  1998cites this paper
• The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111).

  1997cites this paper
• History of treatments.

  1997cites this paper
• Significance of leukotriene-A4 hydrolase in the pathogenesis of psoriasis.

  1997cites this paper
• Glucosamine for psoriasis?

  1997cites this paper
• Topical R-85355, a potent and selective 5-lipoxygenase inhibitor, fails to improve psoriasis.

  1996cites this paper
• Milia en plaquemdash;a new site and novel treatment

  1996cites this paper
• Retroauricular bilateral 'milia en plaque'.

  1995cites this paper
• Omega-3s and Immune/Inflammatory Responses

  1995cites this paper
• Lipid mediators, free fatty acids and psoriasis.

  1995cites this paper
• Future psoriasis therapy.

  1995cites this paper
• Potent antagonism of calmodulin activity in vitro, but lack of antiproliferative effects on keratinocytes by the novel leukotriene biosynthesis inhibitor MK‐886

  1995cites this paper
• 5-Lipoxygenase and 12-lipoxygenase: attractive targets for the development of novel antipsoriatic drugs.

  1994cites this paper
• Topical non-steroidal anti-inflammatory drugs: a review of their use and toxicity

  1994cites this paper
• 5‐Lipoxygenase and 12‐Lipoxygenase: Attractive Targets for the Development of Novel Antipsoriatic Drugs. 5‐Lipoxygenase und 12‐Lipoxygenase: Attraktive Target‐Enzyme für die Entwicklung neuer Antipsoriatika

  1994cites this paper
• The fern Polypodium decumanum, used in the treatment of psoriasis, and its fatty acid constituents as inhibitors of leukotriene B4 formation.

  1994cites this paper
• Testing of lipoxygenase inhibitors, cyclooxygenase inhibitors, drugs with immunomodulating properties and some reference antipsoriatic drugs in the modified mouse tail test, an animal model of psoriasis.

  1994cites this paper
• Leukotriene B4 formation during human neutrophil keratinocyte interactions: evidence for transformation of leukotriene A4 by putative keratinocyte leukotriene A4 hydrolase.

  1993cites this paper
• Percutaneous absorption of azidoprofen, a model for a soft anti-inflammatory drug for topical application

  1993cites this paper
• The reduction of azidoprofen: A model for a soft anti-inflammatory drug for topical application

  1993cites this paper
• 5-Lipoxygenase activation in psoriasis: a dead issue?

  1993cites this paper
• A double-blind, randomized, placebo-controlled trial of n-3 fatty acid based lipid infusion in acute, extended guttate psoriasis

  1993cites this paper
• Dose-response effects of dietary gamma-linolenic acid-enriched oils on human polymorphonuclear-neutrophil biosynthesis of leukotriene B4.

  1992cites this paper
• Effects of the phthalazinone azelastine on epidermal metabolism after mechanical skin irritation.

  1992cites this paper
• 5-lipoxygenase inhibitors and their anti-inflammatory activities.

  1992cites this paper
• [Psoriasis and non steroidal anti-inflammatory agents].

  1992cites this paper
• Rationales for drug development in inflammation: eicosanoids and oxygen-derived free radicals.

  1991cites this paper
• Topical 5-lipoxygenase inhibitors in the treatment of psoriasis

  1991cites this paper
• Clinical and biochemical effects of an oral leukotriene biosynthesis inhibitor (MK886) in psoriasis.

  1991cites this paper
• Leukotriene antagonists and inhibitors of leukotriene biosynthesis as potential therapeutic agents.

  1991cites this paper
• [Trends in the development of lipoxygenase inhibitors].

  1991cites this paper
• Alpha-linolenic acid: functions and effects on linoleic acid metabolism and eicosanoid-mediated reactions.

  1991cites this paper
• Long-term administration of highly purified eicosapentaenoic acid provides improvement of psoriasis.

  1991cites this paper
• Dietary supplementation with ethyl ester concentrates of fish oil (n-3) and borage oil (n-6) polyunsaturated fatty acids induces epidermal generation of local putative anti-inflammatory metabolites.

  1991cites this paper
• Essential fatty acids and the skin

  1991cites this paper
• Blood levels of vitamin E, polyunsaturated fatty acids of phospholipids, lipoperoxides and glutathione peroxidase in patients affected with seborrheic dermatitis.

  1991cites this paper
• Inhibition of prostaglandin and leukotriene generation by the plant alkaloids tetrandrine and berbamine.

  1990cites this paper
• Leukotrienes and inflammation.

  1990cites this paper
• Activation of the alternative pathway of complement in psoriatic lesional skin.

  1990cites this paper
• Lipoxygenase products of arachidonic acid in psoriasis, atopic dermatitis, and experimental arthritis.

  1990cites this paper
• Antioxidant-based inhibitors of leukotriene biosynthesis. The discovery of 6-[1-[2-(hydroxymethyl)phenyl]-1-propen-3-yl]-2,3-dihydro-5- benzofuranol, a potent topical antiinflammatory agent.

  1990cites this paper
• Dermatological Drug Development — A Review of Some Important Issues

  1990cites this paper
• Implications of dietary oils and polyunsaturated fatty acids in the management of cutaneous disorders.

  1989cites this paper
• Guinea pig epidermis generates putative anti-inflammatory metabolites from fish oil polyunsaturated fatty acids

  1989cites this paper
• Essential fatty acids in clinical dermatology.

  1989cites this paper
• Monocyte and neutrophil chemotaxis in psoriasis. Clinical and experimental studies.

  1989cites this paper
• Benoxaprofen inhibits the adhesion of human monocytes to cultured vascular endothelium

  1989cites this paper
• Essential Fatty Acids and Eicosanoids in Cutaneous Inflammation

  1989cites this paper
• Cutaneous pharmacology: perspectives on the growth of investigation of mediators of inflammation.

  1989cites this paper
• The "priming phenomenon" in the acute phototoxicity of erythropoietic protoporphyria.

  1989cites this paper
• Milia en plaque.

  1989cites this paper
• Essential fatty acids and the skin.

  1989cites this paper
• 5-aminosalieylie acid in a cream base improves psoriasis. A double-blind study

  1989cites this paper
• Non-steroidal Anti-inflammatory Agents and the Skin

  1989cites this paper
• Prostaglandins, Leukotrienes, Related Compounds and Their Inhibitors

  1989cites this paper
• Dérivés du 2-oxindole-1-carboxamide, substitués en position 3, utilisés comme inhibiteurs de la biosynthèse de l'interleukine-1

  1989cites this paper
• Adverse reactions to isotretinoin. A report from the Adverse Drug Reaction Reporting System.

  1988cites this paper
• Effect of dietary supplementation with n‐3 fatty acids on clinical manifestations of psoriasis

  1988cites this paper
• The Respiratory Burst and Psoriasis

  1988cites this paper
• [Mechanisms of cutaneous accidents related to non-steroidal anti-inflammatory agents].

  1988cites this paper
• Epidermal Growth

  1988cites this paper
• Eicosanoids in Dermatology

  1988cites this paper
• Psoriasis: Hyperproliferative/inflammatory skin disorder

  1988cites this paper
• Prostaglandins, leukotrienes, phospholipase, platelet activating factor, and cytokines: an integrated approach to inflammation of human skin.

  1988cites this paper
• The Role of Eicosanoids in Inflammatory Disorders of the Skin

  1988cites this paper
• A Case of Psoriasis Induced After Allergic Drug Eruption due to Quinidine Sulfate

  1988cites this paper
• Psoriasis and leukocyte chemotaxis.

  1987cites this paper
• Eicosanoids in psoriasis--15-HETE on the stage.

  1987cites this paper
• Nonsteroidal anti-inflammatory drugs. Their use in dermatology.

  1987cites this paper
• [Calmodulin and psoriasis].

  1987cites this paper
• [The mode of anti-inflammatory action of a topical non-steroidal anti-inflammatory drug, etofenamate].

  1987cites this paper